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The self-aggregation in aqueous solution of a new neo-pentyl amide of the 3-β-
amino derivative of cholic acid (Na-n-penC) has been investigated in aqueous solution 
by surface tension and steady state-fluorescence spectroscopy of pyrene (used as a 
probe). The nature of the agregates was determined by transmission electron 
microscopy (TEM) revealing that vesicles are formed. The structure of the compound in 






Bile salts are natural biosurfactants segregated into the gallbladder by the liver 
as main components of bile. They play an important role in the digestive process.1-3 
Derivatives substituted at the 3-position have shown important biological activity and 
enhancement of the aggregation properties respect the natural analogues. For example, 
the new derivatives are used as hypolipemics,4,5 MRI agents,6-8 cholesterol-dissolving 
agents,9 antibacterial agents,10 antifungic agents,11 or ink additives.12 Other derivatives 
form coloured gels in alcohols13 in the presence of an acceptor, or are linked to crown 
ethers.14  
Compounds with an amide bond to link the steroid and the subtituent group 
moieties are very attractive because its stability in different media. A typical synthetic 
routine involves the preparation of the 3-β-aminoderivative of the bile acid (this group 
being protected as a methyl ester)15,16 and its condensation with any acid or acyl 
chloride. The hydrolysis of the ester bond and neutralization by NaOH are finally 
required to obtain the new steroid derivative in salt form (Figure 1). A example of this 
methodology can be seen in our recent paper concerning the formation of laminar 



































Figure 1.: Synthesis of bile acid derivatives. 
 
The present communication deals with the synthesis, chemical characterization 
and preliminary study of the self-aggregation behavior of a new t-butylderivative of 
cholic acid (Na-n-
penC; Figure 2). 
 
 




 Commercial cholic acid (Sigma-Aldrich) was esterified using the method of 
Gouin and Zhu.15  The methyl ester of cholic acid was purified by crystallization from 
methanol and dried in vacuo at 65ºC. The ester was converted in the 3-β-amino 
derivative by using a modification of the method described by Anelli et al.16  
The reaction was carried out in argon atmosphere and THF (dried over 
sodium/benzophenone).18 The amine was purified by column chromatography and dried 












carried out in dried CHCl3 under inert atmosphere, in the presence of  triethylamine as 
catalyst. Once the solvent is removed, the product is purified by column 
chromatography (20:1 ethyl acetate:methanol. The hydrolysis of the ester, and the salt 
formation was carried out by using procedures described elsewhere.19 Solutions of Na-
tbuC (5 mM and 10 mM) for NMR (one dimension: 1D; two dimensions: 2D) 
experiments were prepared in D2O (99,90%, from SDS). Other chemicals were used as 
provided by Aldrich. 
NMR experiments were performed in a Bruker AMX-500 spectrometer 
(frequency operation 1H: 500 MHz; 13C: 125 MHz). X ray data were obtained with a 
Enraf Nonius FR590 at 25ºC, diffraction nradiation wavelength 0.71069Å (MoK\α). 
Crystals were obtained from 1:1 acetone/water mixture. Surface tension measurements 
were made in a K10ST Krüss tensiometer. A Hitachi F3010 fluorimeter was used for 
fluorescence experiments. TEM images were done at room temperature in a JEOL JEM-
1011 instrument, operated at 80 kV, equipped with a MegaView III camera. For the 
measurements, the samples were prepared by deposition of a drop of a 1mM solution 
onto carbon-coated copper grids. 
 
Results and discussion. 
The product was obtained in 16% (sequence yield) with high purity confirmed 
by TLC. FAB-Mass spectra confirmed it since a value of M+Na+ 550.5 g/mol 
(theoretical value: 550.71 g/mol) was obtained for the compound.  
The partial resolution of the 1-D (1H, 13C, DEPT) and 2-D (COSY, ROESY, 
HMQC, HMBC) experiments afforded relevant evidences of the compound structure. 
Figure 3 shows the principal assignments in the 1H NMR spectrum. Protons 3, 7, 12, 18, 
19, 21 and the methylene and methyl signals from the substituting group were clearly 
determined by cross peaks analysis of COSY and confirmed by ROESY experiments. 
Based on these, other proton signals were elucidated.  
Previous data, DEPT and HMQC, allowed to assign most of the 13C NMR 
spectrum (Figure 4). Signal at 187.6 ppm was assigned to the carbonylate group and 
that one at  177.8 ppm to the amide moiety. HMBC cross peaks are evident from the 
amide carbonyl and the α-methylene group 26. Other correlations in HMBC were H26-






















































































































Figure 4: Assignment of 13C NMR spectrum (principal signals). 
 
The crystal confirms the structure of the compound. Table 1 resume the cell 
parameters of the crystal (colourless) of Na-tbuC in acid form (H-tbuC). Figure 5 
resume some significant images of the structure. 
 
Space Group P212121 
Cell Lengths a=8.4360(8);  b=14.466(3); c=25.164(2) Å 
Cell Angles α 90º;  β 90º;  γ 90º 
Cell Volume 3070.89 Å3 
Z,Z´ Z: 4; Z': 0 
R-factor 7.04 
Table 1: Cell parameters of the H-n-penC crystal. 
 
Figure 5 (left) shows the packing of the crystal . Figure 5 (right) shows that the 
steroid molecules are packed in a back-to-back way evidencing hydrophobic 
interactions between their β-sides. The hydroxy groups form hydrophilic channels 
where water molecules are inserted. 
The hydrophobic interactions are reinforced by the formation of hydrogen bonds, 
implying the oxygen and nitrogen atoms of the amide group, the two hydroxyl groups at 
C7 and C12 and the two oxygen atoms of the carboxylate group of the side chain. Water 
molecules are also involved in the hydrogen bond network, acting as a bridge between 
the two hydroxyl groups of the same steroid molecule and having an additional 
hydrogen bond with the hydroxy group of the carboxylic acid of another molecule.  
 
 
Figure 5: Crystal structure of H-n-penC. 
 
The hydrogen bond network evidence two patterns, a ring (Figure 6 left) and a 
zigzag set (Figure 6 right). The ring involves three steroid molecules and a water 
molecule linked to the hydroxy group at C12 (O12H) and the hydroxy carboxylic group 
of two molecules. The ring is closed by the formation of hydrogen bonds of the amide 
group of the third molecule with former O12H and the carbonyl oxygen of the the 
carboxylic group. The zigzag set follows the sequence O12H-water-O7H-O(amide), the 
hydroxyl groups belonging to the same steroid molecule. The hydrogen bonds 















Figure 6. Hydrogen bond patterns. Left: ring implying three molecules. Right: zigzag set. 
                                 
The self-recognition process between the steroid molecules is different that the 
observed on for H-AdC. This is due to the different packing of molecules in the crystal 
mainly due to the bulkier size of the adamantyl group compared with the neo-pentyl one.  
However the α-methylene group linked to the carbonyl amide allows a preferred 
orientation of the tert-butyl group towards the left side of ring A of the steroid, allowing 
the formation of a hydrogen bond between the carboxylic group at the side with the 
amide nitrogen. This is not possible with the adamantyl substituent because of its 
spherical shape which prevents that hydrogen bond in the H-AdC crystal. 
Surface tension measurements (Wilhelmy plate method) show that the plot of γ 
versus ln [Na-n-penC] is linear until 3.86 mM (Figure 7), reaching a plateau above this 
concentration. This is the typical behavior for a surfactant in aqueous solution, 
suggesting that Na-n-penC self-aggregates in this solvent. This result was confirmed by 
fluorescence That critical concentration value is almost 3 times lower than the critical 
micelle concentration (cmc) of sodium cholate NaC20, indicating that the new 
compound acts as a better surfactant than the natural bile salt. The value for the critical 
concentration was confirm from measurements of the ratio I1/I3 of the intensities of the 
vibronic peaks of pyrene I1 and I3. The large limiting value observed at high surfactant 
concentrations suggest that the aggregated formed is open enough to allow a probe-
water interaction. 
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 Figure 7: Determination of critical association concentracion of Na-n-penC by surface tension 
and fluorescence measurements. 
TEM images were obtained to investigate the nature of the agregates. Typical 
TEM images are provided in Figure 8.  Circular structures with large diameter values 
(>400 nm) are observed. This shape and the large size of the particles suggest that they 
probably are vesicles.  
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